Back to Search
WILLIAM KELLY, PH.D.
PH.D.
Professional Counselor
NPI: 1821722059Individual
Specialties, Licenses & Credentials
Professional CounselorPrimary
Counselor — Professional
Code: 101YP2500X
PC009311(PA)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials.
PMID 19633053·Ann Oncol·2010
8-other
Thiostrepton biosynthesis: prototype for a new family of bacteriocins.
PMID 19265401·J Am Chem Soc·2009
8-other
Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811.
PMID 18989865·Cancer·2008
3-trial
Using computational fluid dynamics to characterize and improve bioreactor performance.
PMID 18338979·Biotechnol Appl Biochem·2008
7-preclinical
Intramolecular cyclizations of polyketide biosynthesis: mining for a "Diels-Alderase"?
PMID 19039353·Org Biomol Chem·2008
6-review
Characterization of the aminocarboxycyclopropane-forming enzyme CmaC.
PMID 17209546·Biochemistry·2007
8-other
Standing guard: Perinuclear localization of an RNA-dependent RNA polymerase.
PMID 16461886·Proc Natl Acad Sci U S A·2006
8-other
Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid.
PMID 16264908·Nat Clin Pract Oncol·2005
6-review
Excision of the epothilone synthetase B cyclization domain and demonstration of in trans condensation/cyclodehydration activity.
PMID 16201763·Biochemistry·2005
8-other
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer.
PMID 15897550·J Clin Oncol·2005
3-trial
Mutational analysis of nocK and nocL in the nocardicin a producer Nocardia uniformis.
PMID 15629944·J Bacteriol·2005
8-other
Mutational analysis and characterization of nocardicin C-9' epimerase.
PMID 15252031·J Biol Chem·2004
8-other
Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases.
PMID 16010459·Pituitary·2004
8-other
Optimal operation of high-pressure homogenization for intracellular product recovery.
PMID 15480808·Bioprocess Biosyst Eng·2004
4-observational
Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.
PMID 14506144·Clin Cancer Res·2003
3-trial
Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancer.
PMID 12796374·Clin Cancer Res·2003
3-trial
Perspectives on plasmid-based gene therapy: challenges for the product and the process.
PMID 12672266·Biotechnol Appl Biochem·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2010 W CHESTER PIKE STE 314
HAVERTOWN, PA 19083 - Phone
- (412) 736-6551
Quick Facts
- NPI
- 1821722059
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile